We are live on ! Find out more
CAG

Csenge Advisory Group Portfolio holdings

AUM $2.18B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
+7.2%
1 Year Est. Return
+16.73%
3 Year Est. Return
+51.88%
5 Year Est. Return
+54.25%
10 Year Est. Return
AUM
$1.29B
AUM Growth
+$85.6M
Cap. Flow
+$14.1M
Cap. Flow %
1.1%
Top 10 Hldgs %
30.51%
Holding
681
New
70
Increased
258
Reduced
245
Closed
85
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRNA icon
551
Moderna
MRNA
$21.5B
$211K 0.02%
+1,177
New +$192K
VHC icon
552
VirnetX Holding Corp
VHC
$52.3M
$209K 0.02%
8,032
-1,100
-12% -$27.3K
MGF
553
Aberdeen Government Markets Income Fund
MGF
$91.6M
$207K 0.02%
62,533
+13,262
+27% +$43.7K
SNPS icon
554
Synopsys
SNPS
$71.5B
$207K 0.02%
+647
New +$203K
VTIP icon
555
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
$206K 0.02%
+4,401
New +$210K
PALC icon
556
Pacer Lunt Large Cap Multi-Factor Alternator ETF
PALC
$210M
$204K 0.02%
+5,804
New +$203K
CPRI icon
557
Capri Holdings
CPRI
$1.77B
$204K 0.02%
+3,551
New +$179K
UFPI icon
558
UFP Industries
UFPI
$4.97B
$203K 0.02%
+2,560
New +$196K
APD icon
559
Air Products & Chemicals
APD
$66.3B
$202K 0.02%
+656
New +$185K
DFS
560
DELISTED
Discover Financial Services
DFS
$201K 0.02%
+2,054
New +$207K
REGN icon
561
Regeneron Pharmaceuticals
REGN
$68.8B
$201K 0.02%
+278
New +$205K
TOTL icon
562
State Street DoubleLine Total Return Tactical ETF
TOTL
$4.11B
$200K 0.02%
5,007
-1,506
-23% -$60.4K
UBS icon
563
UBS Group
UBS
$170B
$194K 0.02%
+10,375
New +$176K
HYI
564
Western Asset High Yield Opportunity Fund Inc
HYI
$134M
$192K 0.01%
15,375
+4,440
+41% +$53.2K
DSL
565
DoubleLine Income Solutions Fund
DSL
$1.21B
$190K 0.01%
17,116
+4,445
+35% +$50.5K
ASX icon
566
ASE Group
ASX
$80.8B
$186K 0.01%
29,635
-2,171
-7% -$12.7K
MPT
567
Medical Properties Trust
MPT
$2.89B
$183K 0.01%
16,412
+2,549
+18% +$29.6K
NVG icon
568
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.65B
$178K 0.01%
14,638
+488
+3% +$5.73K
CLF icon
569
Cleveland-Cliffs
CLF
$6.81B
$178K 0.01%
11,020
-9,575
-46% -$144K
SPE
570
Special Opportunities Fund
SPE
$140M
$175K 0.01%
16,044
+4,994
+45% +$55.7K
BATT icon
571
Amplify Lithium & Battery Technology ETF
BATT
$113M
$171K 0.01%
14,626
+593
+4% +$7.68K
OPK icon
572
Opko Health
OPK
$921M
$146K 0.01%
117,000
WBD icon
573
Warner Bros
WBD
$64.6B
$134K 0.01%
14,180
-933
-6% -$10.5K
NWL icon
574
Newell Brands
NWL
$2.16B
$133K 0.01%
10,181
-11,557
-53% -$158K
MSD
575
Morgan Stanley Emerging Markets Debt Fund
MSD
$147M
$108K 0.01%
+16,574
New +$105K

Similar funds

Csenge Advisory Group's Q4 2022 Portfolio in Review

As of Q4 2022, Csenge Advisory Group held 681 positions worth $1.29B, up 7.1% from $1.21B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Csenge Advisory Group's Q4 2022 filing shows 70 new, 258 increased, 245 reduced and 85 closed positions. Its largest new stake was First Trust Smith Unconstrained Bond ETF: 520,730 shares worth $12.6M. The largest sale was First Trust Global Tactical Commodity Strategy Fund, an estimated $10.8M.

By sector, the portfolio is most concentrated in Technology at 4.4% of assets, down from 4.9% a quarter earlier, followed by Financials and Healthcare.

  • Csenge Advisory Group's largest Q4 2022 buy was First Trust Smith Unconstrained Bond ETF: 520,730 shares worth $12.6M.
  • Csenge Advisory Group added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2022, an estimated $18.1M increase.
  • Csenge Advisory Group's biggest Q4 2022 reduction was First Trust Global Tactical Commodity Strategy Fund, cutting an estimated $10.8M.
  • Csenge Advisory Group fully exited iShares 0-1 Year Treasury Bond ETF in Q4 2022, selling an estimated $10.5M.
  • Csenge Advisory Group's ten largest holdings make up 31% of its $1.29B portfolio in Q4 2022.
  • Csenge Advisory Group opened 70 new positions and closed 85 in Q4 2022.
  • Csenge Advisory Group's portfolio value rose 7.1% quarter-over-quarter to $1.29B.

Based on Csenge Advisory Group's 13F filing for Q4 2022, filed 10 Feb 2023.